2008
Ryan White HIV/AIDS Program Data Report
Public Burden Statement: An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this project is 0915-0253, and the expiration date is ##/##/####. Public reporting burden for this collection of information is estimated to average XX hours per respondent annually, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-33, Rockville, Maryland, 20857.
November 28, 2007
HIV/AIDS Bureau
Division of Science and Policy
Health Resources and Services Administration
5600 Fishers Lane, Room 7-90
Rockville, MD 20857
Section 1 (Items 1–22) should be completed by all service providers funded through Title XXVI of the Public Health Service Act as amended by the Ryan White HIV/AIDS Treatment Modernization Act of 2006 (Ryan White HIV/AIDS Program) Parts A, B, C, and D. For the definition of service provider, please refer to the instructions for completing this form.
Provider name:
Provider address:
Street:
City: State:
ZIP Code: __ __ __ __ __ - __ __ __ __
Taxpayer ID #: __ __ - __ __ __ __ __ __ __
Contact information:
Title:
Phone #: (__ __ __) __ __ __ - __ __ __ __
Fax #: (__ __ __) __ __ __ - __ __ __ __
E-mail:
Person completing this form:
Name:
Phone #: (__ __ __) __ __ __ - __ __ __ __
E-mail:
Calendar year for reporting: (mm/dd/yyyy)
Start date: __ __ / __ __ / __ __ __ __
End date: __ __ / __ __ / __ __ __ __
01 = ALL clients receiving a service ELIGIBLE for Part A, B, C, or D funding
02 = ONLY clients receiving a Part A, B, C, or D FUNDED service
Remember: All grantees and providers must use reporting scope “01” unless they have permission from their HRSA project officer to use “02.” All subsequent Items regarding “clients” should be answered relative to the reporting scope you select here.
Provider type:
(Select only one.)
Hospital or university-based clinic
Publicly funded community health center
Publicly funded community mental health center
Other community-based service organization (CBO)
Health department
Substance abuse treatment center
Solo/group private medical practice
Agency reporting for multiple fee-for-service providers
PLWHA coalition
VA facility
Other facility (Specify )
Did you receive funding under Section 330 of the Public Health Service Act (funds community health centers, migrant health centers, and health care for the homeless) during this reporting period?
Yes No Don’t know/unsure
Ownership status:
(Select only one.)
Public/local
Public/State
Public/Federal
Private, nonprofit (Go to Item 8b)
Private, for-profit
Unincorporated
Other
If “Private, nonprofit” was selected in Item 8a, is your organization faith-based?
Yes No
Did your organization receive Minority AIDS Initiative (MAI) funds during this reporting period?
Yes No Don’t know/unsure
Source of Ryan White HIV/AIDS Program funding: (Check all that apply.)
Part A
Name of grantee(s):
1.
2.
3.
Part B
Name of grantee(s):
1.
2.
3.
Part C EIS
Name of grantee(s):
1.
2.
3.
Part D (including the Adolescent Initiative)
Name of grantee(s):
1.
2.
Part A funding
Total amount of Part A funding expended during this reporting period (rounded to the nearest dollar):
$
Of the amount in Item 11a, how much is from the Minority AIDS Initiative (rounded to the nearest dollar):
$
Part B funding
Total amount of Part B funding expended during this reporting period (rounded to the nearest dollar):
$
Of the amount in Item 12a, how much is from the Minority AIDS Initiative?
$
Part C EIS funding
Total amount of Part C EIS funding expended during this reporting period (rounded to the nearest dollar):
$
Of the amount in Item 13a, how much is from the Minority AIDS Initiative (rounded to the nearest dollar):
$
Part D (including the Adolescent Initiative) funding
Total amount of Part D funding expended during this reporting period (rounded to the nearest dollar):
$
Of the amount in Item 14a, how much is from the Minority AIDS Initiative (rounded to the nearest dollar):
$
Amount of Part A, B, C, or D Ryan White HIV/AIDS Program funds expended on oral health care during this reporting period (rounded to the nearest dollar):
$
During this reporting period, did you provide the grantee with support in . . . ? (See instructions for definitions; Check “Yes” or “No” for each service.)
Planning or evaluation Yes No
Administrative or technical support Yes No
Fiscal intermediary services Yes No
Technical assistance Yes No
Capacity development Yes No
Quality management Yes No
Check this box if the services listed in Item 16 were the only services you provided using Ryan White HIV/AIDS Program funds. If so, STOP HERE and do not complete the remainder of this form.
NOTE: Those who provided a direct service other than those listed in Item 16 should continue with Item 17a.
NOTE: Third party administrators who processed fee-for-service reimbursements to providers of eligible services should continue with Item 17a.
a. Did you administer an AIDS Drug Assistance Program (ADAP) or local AIDS Pharmaceutical Assistance (APA) program that provides HIV/AIDS medication to clients during this reporting period?
Yes
No (Skip to Item 18.)
State ADAP
Local APA program or dispense pharmaceuticals to clients
If the ONLY type of program you administered was a State ADAP, and you offered no other services under the Ryan White HIV/AIDS Program during this reporting period, STOP HERE. You are finished with this form. If you offered a Local APA or dispense pharmaceuticals , then you must continue to complete this form.
Did you provide a Health Insurance Program (HIP) during this reporting period? (Do not include health insurance funded under ADAP as a part of HIP.)
Yes, and this was the only service your agency provided with Ryan White HIV/AIDS Program funding during this reporting period. (Skip to Section 7.)
Yes, and your agency provided other services with Ryan White HIV/AIDS Program funding during this reporting period.
No
Indicate which of the following populations were especially targeted for outreach or services during this reporting period. (Check box for each group targeted.)
Migrant or seasonal workers
Rural populations other than migrant or seasonal workers
Women
Children
Racial/ethnic minorities/communities of color
Homeless
Gay, lesbian, and bisexual youth
Gay, lesbian, and bisexual adults
Incarcerated individuals
All adolescents
Runaway or street youth
Injection drug users
Non-injection drug users
Parolees
Other (specify: )
Which of the following categories describes your agency? (Check all that apply.)
An agency in which racial/ethnic minority group members make up more than 50% of the agency’s board members
Racial/ethnic minority group members make up more than 50% of the agency’s professional staff members in HIV direct services
Solo or group private health care practice in which more than 50% of the clinicians are racial/ethnic minority group members
Other “traditional” provider that has historically served racial/ethnic minority clients but does not meet any of the criteria above
Other type of agency or facility
Total paid staff, in FTEs, funded by any Part of the Ryan White HIV/AIDS Program:
Paid staff FTEs
Total volunteer staff, in FTEs, dedicated to HIV care:
Volunteer staff FTEs
Service providers funded under all Parts should complete this section. Clients reported in this section should include your HIV-infected, HIV-indeterminate, and HIV-affected population, whether receiving core medical services or support services. Affected clients include those who are HIV-negative as well as those with unknown HIV status. An affected client must be linked to a client infected with HIV/AIDS. An indeterminate client is a child under the age of 2, born to a mother who is HIV-infected, and whose status is not yet definite.
Remember your reporting scope. If you chose reporting scope “01” in Item 6, provide information on all clients who received a service eligible for Ryan White HIV/AIDS Program funding. If you chose reporting scope “02” in Item 6, include only clients who received services funded by Part A, B, C, and/or D.
Total number of unduplicated clients:
HIV-positive
HIV-indeterminate (under 2 years)
HIV-negative (affected)
Unknown/unreported (affected)
Total
Total number of new clients:
HIV-positive
HIV-indeterminate (under 2 years)
HIV-negative (affected)
Unknown/unreported (affected)
Total
Gender:
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Male |
|
|
|
Female |
|
|
|
Transgender |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Age (at the end of reporting period):
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Under 2 years |
|
|
|
2–12 years |
|
|
|
13–24 years |
|
|
|
25–44 years |
|
|
|
45–64 years |
|
|
|
65 years or older |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Race and Ethnicity:
a. HIV-positive/indeterminate:
Number of clients: |
Hispanic |
|
Non-Hispanic |
American Indian or Alaska Native |
|
|
|
Asian |
|
|
|
Black or African American |
|
|
|
Native Hawaiian or Other Pacific Islander |
|
|
|
White |
|
|
|
More than one race |
|
|
|
Not reported |
|
|
|
Total |
|
|
|
b. HIV-affected:
Number of clients: |
Hispanic |
|
Non-Hispanic |
American Indian or Alaska Native |
|
|
|
Asian |
|
|
|
Black or African American |
|
|
|
Native Hawaiian or Other Pacific Islander |
|
|
|
White |
|
|
|
More than one race |
|
|
|
Not reported |
|
|
|
Total |
|
|
|
Household income (at the end of reporting period):
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Equal to or below the Federal poverty level |
|
|
|
101–200% of the Federal poverty level |
|
|
|
201–300% of the Federal poverty level |
|
|
|
> 300% of the Federal poverty level |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Housing/living arrangements (at the end of reporting period):
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Permanently housed |
|
|
|
Non-permanently housed |
|
|
|
Institution |
|
|
|
Other |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Medical insurance (at the end of reporting period):
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Private |
|
|
|
Medicare |
|
|
|
Medicaid |
|
|
|
Other public |
|
|
|
No insurance |
|
|
|
Other |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
HIV/AIDS status (at the end of reporting period):
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
HIV-positive, not AIDS |
|
|
|
HIV-positive, AIDS status unknown |
|
|
|
CDC-defined AIDS |
|
|
|
HIV-indeterminate (under 2 years) |
|
|
|
HIV-negative (affected clients only) |
|
|
|
Unknown/unreported (affected clients only) |
|
|
|
Total |
|
|
|
Clients’ vital/enrollment status (at the end of reporting period):
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Active client, new to program |
|
|
|
Active client, continuing in program |
|
|
|
Deceased |
|
|
|
Inactive |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Service providers funded under all Parts should complete this section. If you offered a particular service, check the box in column 2 and list the number of clients and the total number of visits within each service category. If you offered a particular service but do not know the number of clients or visits during the reporting period, check the unknown box. Include HIV-indeterminate clients in the HIV+ column. Core services for affected clients are not eligible for Ryan White HIV/AIDS Program funding.
Services offered, number of clients served, and total number of visits during this reporting period:
|
1 |
2 |
3a |
3b |
4a |
4b |
||
|
Service Categories |
Check if service was offered |
Total # of unduplicated clients |
Check if # of clients unknown |
Total # of visits during reporting period |
Check if # of visits unknown |
||
HIV+ |
Affected |
HIV+ |
Affected |
|||||
|
CORE SERVICES |
|
||||||
a. |
Outpatient/ambulatory medical care |
|
|
|
|
|
|
|
b. |
AIDS Pharmaceutical Assistance (local)/dispense pharmaceuticals |
|
|
|
|
|
|
|
c. |
Oral health care |
|
|
|
|
|
|
|
d. |
Early intervention services (Parts A and B) |
|
|
|
|
|
|
|
e. |
Health Insurance Premium & Cost Sharing Assistance |
|
|
|
|
|
|
|
f. |
Home health care |
|
|
|
|
|
|
|
g. |
Home and community-based health services |
|
|
|
|
|
|
|
h. |
Hospice services |
|
|
|
|
|
|
|
i. |
Mental health services |
|
|
|
|
|
|
|
j. |
Medical nutrition therapy |
|
|
|
|
|
|
|
k. |
Medical case management (including treatment adherence) |
|
|
|
|
|
|
|
l. |
Substance abuse services–outpatient |
|
|
|
|
|
|
|
|
SUPPORT SERVICES |
|
||||||
m. |
Case management (non-medical) |
|
|
|
|
|
|
|
n. |
Child care services |
|
|
|
|
|
|
|
o. |
Pediatric development assessment/early intervention services |
|
|
|
|
|
|
|
p. |
Emergency financial assistance |
|
|
|
|
|
|
|
q. |
Food bank/home-delivered meals |
|
|
|
|
|
|
|
r. |
Health education/risk reduction |
|
|
|
|
|
|
|
s. |
Housing services |
|
|
|
|
|
|
|
t. |
Legal services |
|
|
|
|
|
|
|
u. |
Linguistics services |
|
|
|
|
|
|
|
v. |
Medical transportation services |
|
|
|
|
|
|
|
w. |
Outreach services |
|
|
|
|
|
|
|
x. |
Permanency planning |
|
|
|
|
|
|
|
y. |
Psychosocial support services |
|
|
|
|
|
|
|
z. |
Referral for health care/supportive services |
|
|
|
|
|
|
|
aa. |
Rehabilitation services |
|
|
|
|
|
|
|
ab. |
Respite care |
|
|
|
|
|
|
|
ac. |
Substance abuse services-residential |
|
|
|
|
|
|
|
ad. |
Treatment adherence counseling |
|
|
|
|
|
|
|
Parts A, B, C, and D grantees/service providers that selected the eligible reporting scope “01” in Item 6, and provided HIV-antibody counseling and testing during this reporting period, must report on all Items in Section 4. Those who selected the funded reporting scope “02” in Item 6, and provided HIV-antibody counseling and testing, but did not use Ryan White HIV/AIDS Program funds for testing during this reporting period, should respond “Yes” to Item 34, “No” to Item 35, and then skip to Section 5.
Report the number of individuals who received HIV counseling and testing during the reporting period. This number should include ALL individuals who received HIV counseling and testing in your program, whether or not they were reported as clients in Section 2. This is the only section of the Ryan White HIV/AIDS Program Data Report where individuals who are not considered clients may be reported.
NOTE: HIV counseling and testing are funded as components of Early Intervention Services for Parts A and B. HIV counseling and testing are required components of a Part C program. Part D funds may be used to support these services.
a. Were HIV counseling and testing provided as part of your program during this reporting period?
Yes (Continue.)
No (Skip to Section 5.)
NOTE: If HIV counseling and testing were the ONLY services you provided, complete only Sections 1 and 4.
Indicate the total number of infants tested during this reporting period.
___________ Number of infants tested
Were Ryan White HIV/AIDS Program funds used to support HIV counseling and testing services during this reporting period?
Yes (Continue.)
No (Skip to Section 5 if you selected scope “02.”)
How many individuals received HIV pretest counseling during this reporting period?
Number of:
___________ Confidential
___________ Anonymous
(If answer to both categories is “0,” skip to Item 41a.)
How many individuals were tested for HIV antibodies during this reporting period?
Number of:
___________ Confidential
___________ Anonymous
Of the individuals who were tested for HIV antibodies (Item 37 above), how many had a positive test result during this reporting period?
Of the individuals who were tested for HIV antibodies (Item 37 above), how many received HIV-posttest counseling during this reporting period, regardless of test results?
Number of:
___________ Confidential
___________ Anonymous
Of the individuals who tested POSITIVE (Item 38 above), how many did NOT return for HIV-posttest counseling during this reporting period?
a. Did your program offer partner notification services during this reporting period?
Yes
No (Skip to Section 5.)
If “Yes” in Item 41a, how many at-risk partners were notified during this reporting period?
This section should be completed by all medical service providers funded through the Ryan White HIV/AIDS Program Parts A, B, C, or D. This section should include only clients who were HIV-positive/indeterminate and had at least one outpatient/ambulatory medical care visit during the reporting period. It is expected that grantees who contract with multiple fee for service medical providers will report the medical information for all providers that do not complete a Data Report.
Total number of unduplicated clients with visits for outpatient/ambulatory medical care by gender:
Male
Female
Transgender
Unknown/unreported
Total
For all clients with visits for outpatient/ambulatory medical care (total in Item 42 above), indicate the number of clients with:
1 outpatient/ambulatory medical care visit
2 visits
3-4 visits
5 or more visits
Number for whom visit count is unknown
Total
Total number of clients who were HIV-positive/ indeterminate with each of the listed risk factors for HIV infection:
Clients with more than one reported mode of exposure to HIV are counted in the exposure category listed first in the hierarchy, except for males with a history of both sex with men and injection drug use. They are counted in the separate category, MSM and IDU.
Men who have sex with men (MSM)
Injection drug user (IDU)
Men who have sex with men and injection drug user (MSM and IDU)
Hemophilia/coagulation disorder
Heterosexual contact
Receipt of transfusion of blood, blood components, or tissue
Mother with/at risk for HIV infection (perinatal transmission)
Other
Undetermined/unknown/risk not reported or identified
Total
Number of clients (reported in Item 42) who received HIV-outpatient/ambulatory medical care from your agency for the first time during this reporting period:
New clients
Of the clients who were new to HIV-outpatient/ambulatory medical care (Item 45 above), indicate how many received the following tests at least once during this reporting period:
CD4 Count
Viral Load
Latent tuberculosis (TB) testing:
Number of clients for whom a latent TB test (skin or blood) was indicated during this reporting period:
Of those clients reported in Item 47a above, list the number of clients who received a TB test (skin or blood) during this reporting period:
Of those clients reported in Item 47b above, how many were:
Negative
Positive
Indeterminate
Unknown (did not return for reading; lost to follow-up)
Of those clients who tested positive in Item 47c above, how many received:
Treatment of Latent Tuberculosis Infection (LTBI)
Treatment for active TB disease
Unknown/lost to follow-up
Of those clients who started treatment (in Item 47d), how many:
Completed treatment of LTBI
Completed treatment for active TB disease
Are currently undergoing treatment for either LTBI or active TB disease
Are unknown, lost to follow-up, or did not complete treatment
Number of clients who received each of the following at any time during this reporting period:
Screening/testing for syphilis
Treatment for syphilis
Screening/testing for any sexually transmitted infection (STI) other than syphilis
Treatment for an STI (other than syphilis)
Screening/testing for hepatitis C
Treatment for hepatitis C
Number of clients who were newly diagnosed with AIDS during this reporting period (See instructions for the criteria for an AIDS diagnosis):
Number of HIV-positive clients known to have died during this reporting period:
Number of clients on the following types of antiretroviral therapies at the end of the reporting period:
None
HAART
Other (mono or dual therapy)
Unknown/unreported
Total
Number of women who received a pelvic exam and cervical Pap test during this reporting period:
Pregnancy:
Number of women who were HIV-positive and were pregnant during this reporting period:
Number of pregnant women (Item 53a above), who entered prenatal care in the:
First trimester
Second trimester
Third trimester
At time of delivery
Total
Number of pregnant women (Item 53a above), who received antiretroviral medications to prevent the transmission of HIV to their children:
Number of infants delivered to pregnant women (Item 53a above):
Report the HIV status at the end of the reporting period of the infants delivered (Item 53d above):
HIV-positive, confirmed
HIV-indeterminate
HIV-negative, confirmed
What type of quality management program did your agency use to assess services by medical providers during this reporting period? (Check only one.)
None
Quality management program introduced this reporting period
Established quality management program
Established program with new quality standards added this reporting period
Section 6.1 should be completed by Part C grantees/service providers. Section 6.2 should be completed by Part D, including Adolescent Initiative, grantees/service providers. Part A and Part B grantees should skip to Section 7.
Section 6.1 should be completed only by Part C grantees/service providers that provide primary health care services with Part C funds. Include all of your clients who are HIV-positive or HIV-indeterminate and have received at least one primary health care service during the reporting period, regardless of the funding source for that service. Primary health care services include medical, subspecialty care, dental, nutrition, mental health and substance abuse treatment, medical case management, and pharmacy services; as well as radiology, laboratory and other tests for diagnosis and treatment planning; HIV counseling and testing; and the cost of making and tracking referrals for medical care. An indeterminate client is a child under the age of 2, born to a mother who is HIV-infected, and whose status is not yet definite.
The number of clients reported in Section 6.1 should be less than or equal to the number of unduplicated HIV- positive/indeterminate clients reported in Section 2.
If the number of clients reported in Section 6.1 is equal to the number of unduplicated HIV-positive/indeterminate clients reported in Section 2, check here. (Skip to Item 59.)
a. Total number of unduplicated clients during this reporting period who were:
HIV-positive
HIV-indeterminate (under 2 years)
Number of unduplicated HIV-positive/indeterminate clients who were new clients during this reporting period
Gender (of HIV-positive/indeterminate clients) reported in Item 55a:
Male
Female
Transgender
Unknown/unreported
Total
Age (of HIV-positive/indeterminate clients) reported in Item 55a:
Under 2 years
2–12 years
13–24 years
25–44 years
45–64 years
65 years or older
Unknown/unreported
Total
Race and Ethnicity (of HIV-positive/indeterminate clients) reported in Item 55a:
Number of clients: |
Hispanic |
|
Non-Hispanic |
American Indian or Alaska Native |
|
|
|
Asian |
|
|
|
Black or African American |
|
|
|
Native Hawaiian or Other Pacific Islander |
|
|
|
White |
|
|
|
More than one race |
|
|
|
Not reported |
|
|
|
Total |
|
|
|
Number of clients who were HIV-positive/indeterminate who received at least one primary health care service during this reporting period by race, ethnicity, gender, and age.
|
Age |
Under 2 years |
2–12 years |
13–24 years |
25–44 years |
45–64 years |
65 years and older |
Age unknown |
Total |
||||||||
Race |
Ethnicity Gender |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
American Indian or Alaska Native |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asian |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Black or African American |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Native Hawaiian or Other Pacific Islander |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
White |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
More than one race |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Not reported |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of clients who were HIV-positive/indeterminate who received at least one primary health care service during this reporting period by HIV exposure category, gender, race and ethnicity.
|
Race |
American Indian/ Alaska Native |
Asian |
Black or African American |
Native Hawaiian or Other Pacific Islander |
White |
More than one race |
Not reported |
Total |
||||||||
HIV Exposure Category |
Ethnicity Gender |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Men who have sex with men (MSM) |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Injection drug user (IDU) |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MSM and IDU |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hemophilia/ coagulation disorder |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Heterosexual contact |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Receipt of transfusion of blood, blood components, or tissue |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mother with/at risk for HIV infection (perinatal transmission) |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of clients who were HIV-positive/indeterminate who received at least one primary health care service during this reporting period by HIV exposure category, gender, and age.
HIV Exposure Category |
Gender |
Under 2 years |
2–12 years |
13–24 years |
25–44 years |
45–64 years |
65 years and older |
Age unknown |
Total |
Men who have sex with men (MSM) |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
||
Transgender |
|
|
|
|
|
|
|
||
Unknown/ unreported |
|
|
|
|
|
|
|
||
Injection drug user (IDU) |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
||
Transgender |
|
|
|
|
|
|
|
||
Unknown/ unreported |
|
|
|
|
|
|
|
||
MSM and IDU |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
||
Transgender |
|
|
|
|
|
|
|
||
Unknown/ unreported |
|
|
|
|
|
|
|
||
Hemophilia/ coagulation disorder |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
Heterosexual contact |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
||
Transgender |
|
|
|
|
|
|
|
||
Unknown/ unreported |
|
|
|
|
|
|
|
||
Receipt of transfusion of blood, blood components, or tissue |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
Mother with/at risk for HIV infection (perinatal transmission) |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
Other |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
|
Total |
Male |
|
|
|
|
|
|
|
|
Female |
|
|
|
|
|
|
|
|
|
Transgender |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
|
|
|
|
|
|
|
|
Cost and revenue of primary health care* and other programs† during this reporting period:
Total cost of providing service:
$ Primary health care
$ Other program
Part C grant funds expended:
$ Primary health care (excluding pharmaceuticals)
$ Other program
$ Pharmaceuticals
Direct collections from clients:
$ Primary health care
$ Other program
Reimbursements received from third party payer:
$ Primary health care
$ Other program
All other sources of income:
$ Primary health care
$ Other program
*Includes medical, subspecialty care, dental, nutrition, mental health and substance abuse treatment, medical case management, and pharmacy services; as well as radiology, laboratory and other tests for diagnosis and treatment planning; HIV counseling and testing; and the cost of making and tracking referrals for medical care.
†Includes non-medical case management and eligibility assistance, outreach, social work, health education, and risk reduction. If you are providing a Part C-eligible service, include it, even if it is not being funded under your grant.
a. Were services available through your Early Intervention Services (EIS) program provided at more than one site during this reporting period?
Yes
No (Skip to Item 64.)
If “Yes” to Item 63a, number of sites at which Early Intervention Services were provided during this reporting period:
Please indicate which of the following primary health care services were made available to your clients who were HIV-positive or HIV-indeterminate during this reporting period. (Choose “Yes, within the EIS program” if you offered the service directly and/or through a contractual relationship with another service provider. Choose “Yes, through referral” if it was offered by another agency with which you had no remunerative relationship but to whom you referred. Choose “No” if the service was not available.)
|
Yes, within the EIS program |
Yes, through referral |
No |
|
---|---|---|---|---|
|
▼ |
▼ |
▼ |
|
a. |
Outpatient/ambulatory medical care |
|
|
|
b. |
Dermatology |
|
|
|
c. |
Dispensing of pharmaceuticals |
|
|
|
d. |
Gastroenterology |
|
|
|
e. |
Medical case management |
|
|
|
f. |
Medical nutrition therapy |
|
|
|
g. |
Mental health services |
|
|
|
h. |
Neurology |
|
|
|
i. |
Obstetrics/gynecology |
|
|
|
j. |
Optometry/ophthalmology |
|
|
|
k. |
Oral health care |
|
|
|
l. |
Substance abuse services |
|
|
|
m. |
Other services |
|
|
|
During this reporting period, how many unduplicated clients who were HIV-positive were referred outside the EIS program for any primary health care service that was not available within the EIS program?
Section 6.2 should be completed only by Part D, including Adolescent Initiative, grantees/service providers. Report the Part D clients who were HIV-infected or HIV-indeterminate as well as their affected partner/family member(s). Include only those clients who received Part D services. An indeterminate client is a child under the age of 2, born to a mother who is HIV-infected, and whose status is not yet definite.
The number of clients reported in Section 6.2 should be less than or equal to the number of unduplicated clients reported in Section 2.
If the number of clients reported in Section 6.2 is equal to the number of unduplicated clients reported in Section 2, check here. (Skip to Item 71.)
Total number of unduplicated clients during this reporting period who were:
HIV-positive
HIV-indeterminate (under 2 years)
HIV-negative/unknown
Total number of NEW unduplicated clients during this reporting period who were:
HIV-positive
HIV-indeterminate (under 2 years)
HIV-negative/unknown
Gender:
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Male |
|
|
|
Female |
|
|
|
Transgender |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Age:
Number of clients: |
HIV-positive/ indeterminate |
|
HIV-affected |
Under 2 years |
|
|
|
2–12 years |
|
|
|
13–24 years |
|
|
|
25–44 years |
|
|
|
45–64 years |
|
|
|
65 years or older |
|
|
|
Unknown/unreported |
|
|
|
Total |
|
|
|
Race and Ethnicity:
a. HIV-positive/indeterminate:
Number of clients: |
Hispanic |
|
Non-Hispanic |
American Indian or Alaska Native |
|
|
|
Asian |
|
|
|
Black or African American |
|
|
|
Native Hawaiian or Other Pacific Islander |
|
|
|
White |
|
|
|
More than one race |
|
|
|
Not reported |
|
|
|
Total |
|
|
|
b. HIV-affected:
Number of clients: |
Hispanic |
|
Non-Hispanic |
American Indian or Alaska Native |
|
|
|
Asian |
|
|
|
Black or African American |
|
|
|
Native Hawaiian or Other Pacific Islander |
|
|
|
White |
|
|
|
More than one race |
|
|
|
Not reported |
|
|
|
Total |
|
|
|
Number of clients during this reporting period by gender, HIV status, and age.
Gender |
HIV Status |
Under 2 years |
2–12 years |
13–24 years |
25–44 years |
45–64 years |
65 years and older |
Age unknown |
Total |
Male |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
Female |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
Transgender |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
Unknown/ unreported |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
Total |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
Number of clients during this reporting period by race, ethnicity, HIV status, and age.
|
Age |
Under 2 years |
2–12 years |
13–24 years |
25–44 years |
45–64 years |
65 years and older |
Age unknown |
Total |
||||||||
Race |
Ethnicity HIV Status |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
Hisp |
Non- Hisp |
American Indian or Alaska Native |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asian |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Black or African American |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Native Hawaiian or Other Pacific Islander |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
White |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
More than one race |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Not reported |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
HIV+/indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HIV-/unknown |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of clients who were HIV-POSITIVE OR INDETERMINATE during this reporting period by HIV exposure category and age.
HIV Exposure Category |
Under 2 years |
2–12 years |
13–24 years |
25–44 years |
45–64 years |
65 years and older |
Age unknown |
Total |
Men who have sex with men (MSM) |
|
|
|
|
|
|
|
|
Injection drug user (IDU) |
|
|
|
|
|
|
|
|
MSM and IDU |
|
|
|
|
|
|
|
|
Hemophilia/coagulation disorder |
|
|
|
|
|
|
|
|
Heterosexual contact |
|
|
|
|
|
|
|
|
Receipt of transfusion of blood, blood components, or tissue |
|
|
|
|
|
|
|
|
Mother with/at risk for HIV infection (perinatal transmission) |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Undetermined/unknown |
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
STOP HERE IF YOU DO NOT
PROVIDE HEALTH INSURANCE PROGRAM (HIP) SERVICES
TO YOUR
CLIENTS!
This section should be completed by the state agency and other entities that used Ryan White HIV/AIDS Program funds, except funds from ADAP, to pay for or supplement a client’s health insurance. This section should not be completed by grantees that provide funding to another HIP, or by service providers that only provide vouchers for health insurance. Data on Health Insurance Programs funded through ADAP should be reported in the ADAP Quarterly Reports.
A Health Insurance Program is a program authorized and primarily funded under Part A or Part B of the Ryan White HIV/AIDS Program that makes premium payments, co-payments, deductibles, or risk pool payments on behalf of a client to maintain his/her health insurance coverage.
Total number of UNDUPLICATED clients in this reporting period:
Total number of NEW clients served in this reporting period:
Gender:
Number of clients:
Male
Female
Transgender
Unknown/unreported
Total
Age (at the end of reporting period):
Number of clients:
Under 2 years
2–12 years
13–24 years
25–44 years
45–64 years
65 years or older
Unknown/unreported
Total
Race and Ethnicity:
Number of clients: |
Hispanic |
|
Non-Hispanic |
American Indian or Alaska Native |
|
|
|
Asian |
|
|
|
Black or African American |
|
|
|
Native Hawaiian or Other Pacific Islander |
|
|
|
White |
|
|
|
More than one race |
|
|
|
Not reported |
|
|
|
Total |
|
|
|
Annual expenditures for HIP:
Source |
Total cost |
Undup-licated clients |
Total client-months |
|
|||
Premiums
|
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Deductibles |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Co-payments |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
|
|||
Premiums |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Deductibles |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Co-payments |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
|
|||
Premiums |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Deductibles |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Co-payments |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
TOTAL HEALTH INSURANCE EXPENDITURES |
|||
Premiums |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Deductibles |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Co-payments |
$ _, _ _ _, _ _ _ |
_ _ _ _ |
_ _ _, _ _ _ |
Total expenditures: (Include Item 79 above, “Total Health Insurance Expenditures” plus any other administrative costs.)
$__ __ , __ __ __, __ __ __
Annual HIP funding by Ryan White HIV/AIDS Program sources:
Funding source |
Funding received |
Total Part A funds |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #1 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #2 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #3 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #4 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #5 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #6 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #7 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #8 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #9 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
EMA/TGA #10 __ __ __ __ |
$ _ _, _ _ _, _ _ _ |
Total Part B funds |
$ _ _, _ _ _, _ _ _ |
Total Part C funds |
$ _ _, _ _ _, _ _ _ |
Other Ryan White HIV/AIDS Program funding |
$ _ _, _ _ _, _ _ _ |
Annual HIP funding by other sources:
Funding source |
Funding received |
Federal Section 330 |
$ _ _, _ _ _, _ _ _ |
Other Federal funding |
$ _ _, _ _ _, _ _ _ |
State/Local |
$ _ _, _ _ _, _ _ _ |
Client payments |
$ _ _, _ _ _, _ _ _ |
All other sources not included above |
$ _ _, _ _ _, _ _ _ |
END OF REPORT
Instructions
for CARE Act Data Report
File Type | application/msword |
File Title | nod |
Author | ajas |
Last Modified By | HRSA |
File Modified | 2007-12-03 |
File Created | 2007-11-30 |